Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

A single-center, randomized (1:1) open-label, prospective, stratified study with two parallel arms, designed to evaluate adherence to the adapted physical activity (APA) program for patients participating in an APA program and to compare changes in fatigue at 3 months in patients who have completed adjuvant systemic chemotherapy for cancer and are participating in an APA program.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • •Wiek 18-75 lat
  • •Potwierdzony histologicznie rak (piersi, jelita grubego, jajnika, trzustki, żółci lub żołądka) bez przerzutów
  • •Chemioterapia lecznicza ukończona mniej niż 3 miesiące temu
  • •Dobry ogólny stan zdrowia (skala WHO 0 lub 1)
  • •Brak wznowy nowotworu od końca chemioterapii
  • •Dobrowolna zgoda na udział w badaniu i podpisanie dokumentu
  • •Ubezpieczenie społeczne

✗ Disqualifies

  • •Planowane nowe leczenie raka (poza hormonoterapią)
  • •Wcześniejsza immunoterapia
  • •Problemy z sercem uniemożliwiające ćwiczenia
  • •Niestabilne lub niekontrolowane choroby przewlekłe
  • •Poważne niedożywienie
  • •Niewydolność oddechowa wymagająca tlenu
  • •Cukrzyca z owrzodzeniami stopy
  • •Niezagojone złamanie lub rany

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Maximum age
75 Years
Last updated (source)
September 15, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (1)

Centre Antoine Lacassagne

Nice, France

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/16/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.